Invest in

Repeal Obamacare

3.2%
3.2%
0.4%

Affordable Care May Not Be So Affordable

Not everybody feels good about Obamacare. It’s actually called the Patient Protection and Affordable Care Act of 2010 and was upheld by the Supreme Court in June 2012. Since then, the enactment of new sales taxes, funding cuts, and lower reimbursement rates it contains have had a significant impact on the healthcare system.[1] For example, Obamacare imposes a 2.3% excise tax on the sales of medical devices, which industry lobbyist argue could have an adverse effect on job creation, investment in new research and cut up to half of the profits for medical device companies.[2] Not surprisingly, $150 million has been spent by these companies since 2008[2] to repeal the tax while their stock prices have underperformed the overall healthcare sector and the broader S&P 500 by a wide margin. [3] As the implementation of Obamacare begins on October 1st, 2013, Republicans are committed to repealing parts of bill which they believe negatively impact the healthcare system. See more
3.2%
3.2%
0.4%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Repeal Obamacare Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
49.8% Diagnostics 6.5%
20.4% Quest Diagnostics Incorporated DGX 13.1%
11.1% Myriad Genetics Inc. MYGN 10.1%
7.3% Luminex Corporation LMNX 15.2%
5.8% DexCom Inc. DXCM 1.2%
3.5% Genomic Health Inc. GHDX 5.5%
1.8% NeoGenomics Inc. NEO 47.3%
29.5% Assisted Living 3.8%
11.4% National HealthCare Corporation NHC 0.4%
7.1% The Ensign Group Inc. ENSG 19.1%
6.0% LHC Group Inc. LHCG 9.4%
3.1% Almost Family Inc. AFAM 7.0%
1.9% Capital Senior Living Corp. CSU 29.9%
20.7% Medical Devices 18.9%
6.0% ABIOMED Inc. ABMD 64.6%
3.7% NxStage Medical Inc. NXTM 49.4%
2.2% NuVasive Inc. NUVA 25.1%
2.1% Insulet Corporation PODD 4.1%
2.0% Globus Medical Inc. Class A GMED 7.2%
1.8% Exact Sciences Corporation EXAS 62.0%
1.1% Cardiovascular Systems Inc. CSII 31.1%
1.0% The Spectranetics Corporation SPNC 20.4%
0.9% TrovaGene Inc. TROV 55.4%

Quotes delayed 15 mins. Currently Jul 1, 2016 9:58:27 PM. Fields are marked with -- when data is unavailable.